"The Company recognises that the China infant nutrition market structure is changing rapidly. While consumers still have a strong preference for premium infant nutrition, market growth is being impacted by a more pronounced reduction in the birth rate. In addition, the shift towards China label infant nutrition continues, the rate of new product innovation has ramped up, channels to market are changing and competitive intensity is increasing, with domestic players continuing to gain market share."
Page 12
The increasingly competitive environment compounded by macro factors and evolving market dynamics reiterates the importance of the Company’s current growth strategy review
Page 14
Notwithstanding these actions, the Company estimates it lost market share in the daigou channel during the year, particularly in Stage 1 infant nutrition
As a non holder I ought not be the one bringing this to light as you are all mostly fully invested. No surprise it is a well shorted stock.
A2M Price at posting:
$5.37 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)